The researchers extended an established feedforward motor-cortex model by adding recurrent connections between the specified cortical layers. Synaptic coupling coefficients were derived through a bottom-up approach using microanatomical data and then calibrated against experimental input–output curves with particle swarm optimization. To personalize the model, they optimized three recurrent weighted gains: W_ev, W_iv and W_vv. The model was then used to simulate single-pulse input–output curves, paired-pulse protocols known as short-interval intracortical inhibition, intracortical facilitation and long-interval intracortical inhibition, as well as responses to intermittent and continuous theta-burst stimulation.

One central result was a sigmoidal, nonlinear relationship between TMS intensity and neuronal input. This differed from the linear relationship assumed in previous feedforward models. Recurrent weighted inhibitory gain, W_iv, was critical for generating realistic short-interval intracortical inhibition and was the dominant parameter used to personalize the model. With that parameter, the simulations successfully fit 13 of 18 individual intermittent theta-burst stimulation response profiles and 15 of 18 individual continuous theta-burst stimulation profiles.

The model also connected distinct paired-pulse responses to protocol-specific settings of the same recurrent microcircuit. Short-interval intracortical inhibition and facilitation emerged through different tuning of recurrent activity, while long-interval intracortical inhibition required greater suppression of recurrent excitation. The latter model result was consistent with GABAB mediation. The authors therefore present recurrent inhibitory feedback as a mechanism that helps organize TMS dynamics and may help account for differences among individuals in their responses to stimulation.

Generalization was assessed using an independent continuous theta-burst stimulation dataset that had not been used for the initial calibration. The personalized model produced robust fits on that dataset, supporting its ability to reproduce responses beyond the measurements used to tune it. The authors describe the framework as a mechanistically interpretable approach for linking clinical TMS metrics to specific motor-cortex circuits, with potential value for personalized neuromodulation. However, the reported evidence concerns model construction, calibration and computational validation; it does not demonstrate that the model improves patient outcomes or that its parameters can yet be used to select effective stimulation protocols.

Subject of Research: Personalized neural field modeling of recurrent motor-cortex feedback in TMS-evoked motor potentials

Article Title: Mechanistic Role of Layer 5-to-2/3 Recurrent Feedback in TMS-Evoked Motor Potentials

Article References: Mahmouie, S., Saviz, M., Baghdadi, G., & Towhidkhah, F. (2026). Mechanistic Role of Layer 5-to-2/3 Recurrent Feedback in TMS-Evoked Motor Potentials. Neuroinformatics, 24(4), Article 68. https://doi.org/10.1007/s12021-026-09818-w

Image Credits: AI Generated

DOI: 10.1007/s12021-026-09818-w

Keywords: transcranial magnetic stimulation, motor cortex, neural field theory, recurrent feedback, cortical inhibition, theta-burst stimulation, paired-pulse protocols, inter-individual variability, neuromodulation, Mechanistic, Role, Layer

The choice of the specific parameters measured in this study reflects both practical constraints and the priorities of space medicine. Body weight, core body temperature, blood pressure, heart rate, and peripheral oxygen saturation are inexpensive, quick, and reliable to obtain in a confined habitat without specialized equipment, making them feasible for repeated measurement by crew members themselves. Each parameter also serves as a proxy for a distinct physiological system. Body weight integrates fluid balance, energy intake, and expenditure, and shifts in weight during confinement can signal changes in dietary habits, hydration, or activity levels. Blood pressure and heart rate reflect cardiovascular regulation and, indirectly, autonomic nervous system tone, which is sensitive to stress, sleep quality, and physical activity. Core body temperature relates to thermoregulation and circadian rhythmicity, both of which can be disrupted when natural light cycles and environmental variability are removed. Peripheral oxygen saturation, while generally stable in healthy individuals at sea level, provides a safety margin check that can detect respiratory or environmental problems. Together, these five measures form a minimal but informative panel for monitoring crew health in resource-limited settings.

The pronounced inter-individual variability observed, particularly for body weight and cardiovascular measures, deserves careful attention because it mirrors one of the most consistent findings across analog and spaceflight literature. Individual responses to identical environmental stressors can diverge substantially, influenced by baseline fitness, habitual diet, sleep chronotype, stress coping styles, and prior experience with confined or expeditionary settings. In the Mars500 experiment, for example, crew members showed markedly different patterns of sleep-wake disruption and activity over the 520-day simulated mission, and similar heterogeneity has been documented in Antarctic overwintering personnel. This variability has practical consequences: group-level averages can mask clinically meaningful changes in individual crew members, which argues for personalized monitoring approaches in which each individual serves as their own control. It also complicates the design of analog studies, since small cohorts drawn from a variable population may not represent the range of responses expected in larger, more diverse astronaut corps.

The methodological decision to rely on descriptive statistics rather than inferential testing reflects a common and often underappreciated challenge in analog research. With 40 participants measured at three time points, the dataset is respectable by the standards of analog missions, which frequently involve crews of four to six individuals. Even so, the authors found that several variables deviated from normal distributions, as assessed with Q-Q plots, which undermines the assumptions underlying parametric tests such as repeated-measures analysis of variance. Non-normal distributions of physiological parameters in small samples can arise from genuine biological heterogeneity, from measurement variability, or from the bounded nature of some measures such as oxygen saturation, which clusters near its physiological ceiling. When distributional assumptions fail, inferential tests lose their interpretability, and presenting medians, ranges, and distribution shapes becomes more honest than reporting p-values that may be unstable or misleading. This approach also guards against overinterpreting random fluctuation as meaningful adaptation, a pitfall that has affected some smaller analog studies.

The measurement schedule itself, with assessments on Days 1, 7, and 14, represents a compromise between scientific resolution and operational feasibility. Weekly sampling can capture broad trends and identify whether parameters drift over the mission, but it cannot resolve day-to-day fluctuations that may carry their own information. Heart rate and blood pressure, for instance, are influenced by acute factors such as sleep quality, caffeine intake, exercise timing, and even the stress of being measured, and single daily readings may not distinguish between transient variation and genuine directional change. The authors’ call for higher-frequency monitoring in future studies aligns with a broader trend in space health research toward continuous or near-continuous ambulatory monitoring using wearable sensors. Such devices can capture heart rate variability, activity levels, and sleep patterns around the clock, providing a far richer picture of autonomic adaptation than episodic spot checks. However, wearables introduce their own challenges in confined habitats, including sensor drift, skin irritation, data management, and the psychological effect of constant observation on crew behavior.

The LunAres Research Station itself is worth situating within the broader landscape of analog facilities. Located in Piła, Poland, it operates as an isolated habitat in which crews live and work without access to the external environment for the duration of a mission, simulating key characteristics of what researchers term ICE environments: isolated, confined, and extreme. Unlike facilities that simulate specific planetary surfaces, such as HI-SEAS on Hawaiian volcanic terrain or stations designed around Martian regolith scenarios, LunAres emphasizes the human factors dimension of isolation, with modular living quarters, laboratory space, a gym, and a kitchen arranged around a central research area. This design makes it particularly suitable for studies of behavioral health, crew dynamics, and physiological monitoring under confinement, complementing facilities whose primary value lies in geological or operational realism. The diversity of analog platforms is itself an asset, since different facilities isolate different subsets of the stressors experienced in spaceflight, allowing researchers to attribute effects more precisely.

It is important to recognize what this study deliberately does not model. Microgravity, space radiation, and the specific hazards of launch and landing are absent by definition in a terrestrial habitat, and the authors are explicit that their aim was not to replicate spaceflight physiology. This transparency matters because analog findings are sometimes overextended in popular reporting, with confinement effects conflated with the cardiovascular deconditioning or bone loss caused by weightlessness. What analogs like LunAres isolate is the psychological and behavioral component of spaceflight: the loss of environmental variety, the enforced proximity to a small group, the structured routines, and the separation from family and normal social life. These stressors are genuinely relevant to long-duration missions, and their physiological correlates, such as altered sleep, changed activity patterns, and stress-mediated cardiovascular adjustments, can be studied without the enormous cost and rarity of orbital research. The finding that short-term confinement alone did not perturb basic physiological parameters suggests that, for healthy adults, the psychological stress of a two-week isolation is within the adaptive capacity of normal homeostatic mechanisms.

The emphasis on standardized measurement protocols in the authors’ conclusions points to a persistent weakness in the analog literature. Because analog studies are conducted by many independent groups with different instruments, timing conventions, and definitions of baseline, results are difficult to compare or pool. Blood pressure measured after rest versus after activity, body temperature measured orally versus tympanically, and weight measured at different times of day relative to meals can all yield systematically different values. Establishing community standards for measurement timing, posture, instrumentation, and data reporting would allow individual studies to contribute to a cumulative evidence base rather than existing as isolated snapshots. The authors’ observation that routine parameters are often interpreted without adequate consideration of confounders such as hydration status, circadian phase, and recent physical activity is a pointed reminder that even simple measurements require careful protocol design to be interpretable.

The prospective observational design, in which measurements were planned before the mission and collected at fixed time points, strengthens the study relative to retrospective analyses of mission records, though it remains observational in the strict sense. Without a control group experiencing the same schedule outside confinement, the study cannot attribute any observed change specifically to isolation, and indeed the absence of temporal trends means there is little to attribute. This limitation is inherent to analog research, where the practical and ethical difficulty of isolating a matched control group for two weeks is considerable. Some studies address this by comparing mission data with pre-mission baseline periods or with crew members’ habitual routines, and future LunAres studies could incorporate such baseline extensions to sharpen inference.

Finally, the study’s framing of physiological stability as a finding in its own right, rather than as a failure to detect effects, is a useful corrective to publication norms that favor dramatic results. Demonstrating that a well-controlled two-week confinement does not destabilize basic cardiovascular, thermal, and metabolic markers in healthy adults provides a reassuring data point for short-duration mission planning and establishes a baseline against which longer missions can be compared. The authors’ recommendation to add psychological markers alongside physiological ones acknowledges that the most consequential effects of isolation may be behavioral rather than vital-sign-based, and that integrated monitoring of mood, cognition, sleep, and interpersonal dynamics will be essential as mission durations extend toward the months and years required for lunar surface operations and eventual journeys to Mars.

Subject of Research: Physiological monitoring of healthy adults during a 14-day isolated analog space mission

Article Title: Analytical comparison of physiological parameters in participants during an analog space mission

Article References: Kijak, K., Lubkowska, A., Skomro, P., Ardan, R., Budkowska, M., Gronwald, B., Gronwald, H., Stachowska, E., Kijak, K., Orzechowski, L., Mintus, A., & Lietz-Kijak, D. (2026). Analytical comparison of physiological parameters in participants during an analog space mission. Frontiers in Space Technologies, 7, Article 1752453. https://doi.org/10.3389/frspt.2026.1752453

Image Credits: AI Generated

DOI: 10.3389/frspt.2026.1752453

Keywords: space analog mission, isolation, LunAres Research Station, physiology, blood pressure, heart rate, body temperature, oxygen saturation, space medicine, confinement, inter-individual variability, Analytical

The clinical logic behind platelet-rich plasma, commonly abbreviated PRP, is deceptively simple. Platelets are the blood’s first responders, streaming to sites of injury and releasing a cocktail of growth factors and signaling proteins that orchestrate clotting, inflammation resolution, and tissue rebuilding. By concentrating platelets from a patient’s blood and re-delivering them to a damaged site, clinicians aim to amplify the body’s own repair mechanisms. Because the material is autologous, derived from the patient, it sidesteps immune rejection and disease transmission concerns that complicate donor-derived products. But aging is known to blunt tissue regeneration, raising an uncomfortable question: if regeneration slows with age, does the PRP made from an 80-year-old’s blood still carry the molecular machinery needed to heal?

That is precisely the question addressed by Anna Buisan-Farré, Montserrat Serra-Mas, Marta Otero-Viñas, and colleagues working across the University of Vic – Central University of Catalonia, the Institute for Research and Innovation in Life and Health Sciences in Central Catalonia, and the Institute for Research in Biomedicine in Barcelona. Their study stands out for its focus. Most proteomic investigations of PRP have examined samples from young or mixed-age donors, leaving a substantial evidence gap for the elderly, whose tissues are the ones most in need of regenerative support and whose blood may differ immunologically, hormonally, and in its clotting behavior.

The technical pipeline behind the study reflects the rigor required to make such claims defensible. Blood samples were collected from 32 elderly donors under institutional review board approval with informed written consent. Platelet-rich plasma was prepared by sequential centrifugation, the standard method of separating blood components by density. To release the platelet payload, the researchers activated the platelets with calcium gluconate and heparin, then centrifuged the samples again to strip out residual platelets, leaving behind the soluble protein cargo that a clinician would actually inject. Control plasma samples were processed in parallel to distinguish proteins genuinely concentrated by platelets from those simply circulating in blood.

Mass spectrometry formed the analytical core of the work. Because the most abundant blood proteins, chiefly albumin and immunoglobulins, can mask the rarer signaling molecules of interest, the team first depleted these high-abundance proteins. The remaining proteome was enzymatically digested into peptides and analyzed by liquid chromatography coupled to tandem mass spectrometry, a technique that separates peptides by chemical properties before fragmenting them in the mass spectrometer to infer their amino acid sequences. Bioinformatic pipelines then mapped the identified proteins onto known biological processes using tools such as Gene Ontology biological process annotations and the Kyoto Encyclopedia of Genes and Genomes pathway database.

The headline result is striking: 324 of the 1,378 detected proteins appeared exclusively in the platelet-rich plasma and not in control plasma. Functional analysis showed that the PRP proteome, whether unique to PRP or shared with plasma, was strongly linked to vesicle transport, immune and coagulation processes, cytoskeleton organization, and wound healing. In other words, the concentration step does not merely add platelet fragments; it enriches a coherent biological program centered on the very processes tissue repair demands. Cytoskeleton organization proteins point to cell migration and structural remodeling, while vesicle transport proteins reflect the exosome-rich cargo platelets deliver to injured tissue.

Perhaps the most clinically consequential finding, however, concerns variability. The researchers observed marked inter-individual differences in which proteins were detected across the 32 donor samples, and critically, the proteins showing this person-to-person variability were themselves linked to tissue regeneration processes. That observation carries a double meaning. On one hand, it suggests that not every elderly patient’s PRP preparation will be equally potent, a fact that could explain the notoriously inconsistent results of PRP clinical trials, where some patients respond robustly and others see little benefit. On the other hand, it opens a genuine opportunity for personalized medicine: rapid proteomic or functional screening of a patient’s PRP could, in principle, predict therapeutic quality before injection, or guide dosage and treatment protocols on an individual basis.

The study’s authors are careful about what their data do and do not establish. This is a characterization study, not a clinical trial; it demonstrates that elderly-derived PRP is rich in regenerative proteins and that its composition varies between people, but it does not yet prove that variations in the proteome translate into differences in healing outcomes for patients. Translating these molecular inventories into standardized, efficacy-graded PRP products will require correlating proteomic signatures with clinical endpoints in controlled studies, and the inter-individual variability the team documented is precisely the kind of biological signal that such trials should stratify for.

Still, the implications for an aging global population are considerable. As life expectancy rises, the burden of chronic wounds, osteoarthritis, tendinopathies, and other degenerative conditions grows with it, and the elderly are often the least well served by existing regenerative options. The new proteomic map provides reassurance that age does not strip PRP of its therapeutic cargo: even in advanced age, the platelet concentrate retains a wealth of proteins playing crucial roles in tissue regeneration. At the same time, it hands the field a molecular framework for moving beyond one-size-fits-all formulations toward personalized autologous therapies, where the composition of a patient’s own PRP becomes a measurable, and potentially optimizable, clinical variable. In a therapy long criticized for its biological opacity, that transparency may prove the most regenerative development of all.

The choice of activation agents in the study deserves particular attention, because it shapes what the mass spectrometer ultimately sees. Calcium gluconate mimics the physiological trigger for platelet activation, since rising intracellular calcium is the canonical signal that causes platelet granules to fuse with the cell surface and discharge their contents. Heparin, an anticoagulant, was used alongside it, and the combination allowed the researchers to drive degranulation in a controlled manner before removing the platelet bodies entirely. What remains after this step is the secretome: the soluble proteins, growth factors, and chemokines that would, in a living wound, be released directly at the site of injury. This design choice means the measured proteome approximates the bioactive payload a patient would actually receive, rather than an inventory of intact platelet contents.

The depletion of high-abundance proteins is equally consequential for interpreting the results. Albumin and immunoglobulins dominate blood plasma to such an extent that, undepleted, they can consume the vast majority of the mass spectrometer’s analytical capacity, drowning out low-copy signaling molecules. By removing them first, the team gained sensitivity into the mid- and low-abundance range where many regulatory proteins reside, including those governing extracellular matrix assembly and cell communication. This technical step helps explain why the study resolved nearly 1,400 distinct proteins, a depth of coverage that few earlier PRP characterizations achieved, and why proteins tied to vesicle transport and cytoskeletal dynamics emerged so prominently.

The finding that 324 proteins were detected only in platelet-rich plasma underscores how much the concentration step transforms the starting material. Platelets are not merely passive carriers; they are secretory cells whose alpha granules and dense granules hold a curated cargo accumulated during platelet production in the bone marrow. When activated, this cargo is released together with vesicles and microparticles that can deliver signaling molecules to target cells. The enrichment of vesicle transport proteins in the PRP samples is consistent with this biology, suggesting that the therapeutic effect of PRP may depend not only on soluble growth factors but also on the extracellular vesicles that platelets shed, which are increasingly recognized as mediators of intercellular communication in tissue repair.

The inter-individual variability documented across the 32 donors also invites reflection on its possible origins. Protein detection differences between donors could reflect genuine biological variation in platelet content, differences in circulating plasma proteins, or variation in how each donor’s blood responded to the preparation protocol. Age-related changes in platelet reactivity, chronic low-grade inflammation, comorbidities, and medication use are all plausible contributors in an elderly cohort, although the study design did not dissect these factors individually. What the data establish is that the variability itself concentrates in proteins associated with tissue regeneration, meaning the differences are not random noise scattered across irrelevant functions but are centered on the biology that matters therapeutically.

Methodologically, the work also contributes to reproducibility in a field often criticized for heterogeneity. The researchers reported quality control metrics including false discovery rate control for peptide and protein identification, and they deposited their data in the PRIDE proteomics repository, allowing other laboratories to reanalyze the raw spectra. Such transparency matters because PRP preparations differ widely across clinics in centrifugation protocols, activation methods, and platelet concentrations, making cross-study comparison difficult. A well-annotated molecular reference for elderly-derived PRP, produced under a documented preparation pipeline, gives the field a benchmark against which future formulations can be compared, and a foundation for the stratified clinical trials that will be needed to convert proteomic characterization into therapeutic guidance.

Subject of Research: Proteomic profiling of platelet-rich plasma from elderly individuals for autologous regenerative therapy

Article Title: Comprehensive proteomic profiling of platelet-rich plasma from elderly individuals: insights for autologous therapeutic applications

Article References: Buisan-Farré, A., Serra-Mas, M., Sarri, E., Salgado-Pacheco, V., Arauz-Garofalo, G., Odena-Caballol, A., Vilaseca, M., Gay, M., Ferrer-Solà, M., Masó-Albareda, C., Casals-Zorita, M., & Otero-Viñas, M. (2026). Comprehensive proteomic profiling of platelet-rich plasma from elderly individuals: insights for autologous therapeutic applications. Clinical Proteomics. https://doi.org/10.1186/s12014-026-09630-3

Image Credits: AI Generated

DOI: 10.1186/s12014-026-09630-3

Keywords: platelet-rich plasma, PRP, proteomics, mass spectrometry, elderly, tissue regeneration, regenerative medicine, autologous therapy, wound healing, coagulation, inter-individual variability, Clinical Proteomics